COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice.

COVID-19 SARS-CoV-2 coronavirus morbidity mortality pediatrics prognosis

Journal

Infectious disorders drug targets
ISSN: 2212-3989
Titre abrégé: Infect Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269158

Informations de publication

Date de publication:
2022
Historique:
received: 23 12 2020
revised: 13 04 2021
accepted: 07 06 2021
pubmed: 1 10 2021
medline: 20 7 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

SARS-CoV-2 is the novel coronavirus that causes severe acute respiratory syndrome and could afflict individuals from all walks of life. Children are usually asymptomatic or represent non-specific mild to moderate symptoms; therefore, they often remain undiagnosed and could be potential reservoirs and silent carriers of the virus. Despite the global attention to COVID-19 and its importance in public health, some clinical and paraclinical aspects of this disease in children are still unclear. Thus, we conducted a comprehensive systematic review of available literature to reflect on the current knowledge and practice of the disease among children. This study was a systematic review of current evidence conducted in October 2020. We performed a systematic search using the keywords in online databases. The investigation adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to ensure the reliability and validity of extracted literature and results. We selected and reviewed 23 most related studies out of 1744 identified papers in an initial online search based on the inclusion and exclusion criteria of the present review; of whom 13 were original research studies, and 10 were letters to the editors, commentaries, viewpoints, consensus statements, and perspectives. Although due to the origin of the current pandemic, China was the country with the most publications (12 articles), data from several countries have been included in this review. COVID-19 can also affect children and cause systemic disease with several internal organ involvements. However, the prevalence, severity, and diversity of the symptoms in children are less than in adults. Cough and fever appear to be some of the most common symptoms, followed by other symptoms such as gastrointestinal manifestations. Comorbidities increase the risk of severe COVID-19 in children, and those without underlying conditions are very unlikely to suffer from severe disease. Mental health issues such as anxiety and depression due to the isolated situation caused by pandemics are common findings in children of early ages and should be seriously considered in current practice.

Identifiants

pubmed: 34587889
pii: IDDT-EPUB-118233
doi: 10.2174/1871526521666210929121705
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e290921196908

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Esmaeil Mehraeen (E)

Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.

Shahram Oliaei (S)

HBOT Research Center, Golestan Hospital, Islamic Republic of Iran, Navy and AJA Medical University, Tehran, Iran.

SeyedAhmad SeyedAlinaghi (S)

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

Amirali Karimi (A)

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Pegah Mirzapour (P)

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.

Amir Masoud Afsahi (AM)

Department of Radiology, School of Medicine, University of California, San Diego (UCSD), CA, USA.

Alireza Barzegary (A)

School of Medicine, Islamic Azad University, Tehran, Iran.

Farzin Vahedi (F)

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Mahdi Soleymanzadeh (M)

Ophthalmology Resident at Farabi Hospital, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Farzane Behnezhad (F)

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Javaherian (M)

Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran.

Ghazal Zargari (G)

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Seyed Peyman Mirghaderi (SP)

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Tayebeh Noori (T)

Department of Health Information Technology, Zabol University of Medical Sciences, Zabol, Iran.

Jean-Marc Sabatier (JM)

Université Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculté de Pharmacie, 27 Bd Jean Moulin, 13385, Marseille Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH